We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

GlaxoSmithKline Buys Top European Sports Nutrition Company Maxinutrition

December 13, 2010: 10:17 AM EST

British pharmaceutical firm GlaxoSmithKline announced it will acquire all of the stock of Maxinutrition, a UK company that manufactures protein-enhanced functional nutrition products, from Darwin Private Equity for £162 million, including repayment of outstanding debt. Maxinutrition’s brands include Maximuscle for gaining muscle, strength and power; Maxifuel for sports endurance; and Maxitone for female toning and weight management. Maxinutrition is Europe’s leading sports nutrition company in terms of market share. Sales growth, according to GSK, has been 21percent CAGR over the last three years. Sales were about £36 million for the fiscal year ended April 2010. GSK said it would invest in expanding Maxinutrition’s brands globally wherever GSK has “infrastructure and capabilities.”

GlaxoSmithKline plc, "GSK to strengthen Nutritional Healthcare business with acquisition of Maxinutrition", GSK press release, December 13, 2010, © GlaxoSmithKline plc
Vitality & Better Living
United Kingdom
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Press Release
Products & Brands
Developed by Yuri Ingultsov Software Lab.